Can Cycle Charting Change How We Treat Women?

Raghda Rashad, MBBSIf a patient brings a chart of her recent menstrual cycles into a consultation, many clinicians are likely to dismiss it, missing an opportunity to use a potential diagnostic tool and losing out on valuable insight into her overall health. Fertility Awareness Based Methods (FABMs) have evolved since the 1950s from simple calendar counting for natural family planning into structured biomarker-based protocols. The applications have extended beyond contraception to guide the diagnosis and management of medical conditions.A physician myself, medical school left me unable to decode my own cycles through life transitions and illness. This gap between clinical training and lived reality is what drove me to certify in two FABMs (Billings Ovulation Method and Fertility Education and Medical Management) and to learn two others as a user myself. That experience clarified something we are rarely taught as clinicians: The menstrual cycle is relevant to nearly every area of health, and an FABM-informed cycle charting can show the live progress of the current cycle alongside the accumulated pattern of the previous cycles in a way no single clinical investigation can replicate. This information is not reaching most clinicians in the Middle East and North Africa (MENA) region, including gynecologists. How Fertility Awareness-Based Methods Evolved? Early FABM approaches relied only on counting days to estimate the fertile window. Modern methods teach women to observe and record daily one or more biomarkers and cycle symptoms. Each biomarker tracks a distinct hormonal shift. Cervical mucus changes in response to rising estrogen typically shift from dry or sticky in the early follicular phase to clear, stretchy, and slippery near ovulation, then abruptly drying up after the post-ovulatory progesterone rise.Basal body temperature stays relatively low through the follicular phase, then rises after ovulation as progesterone increases, allowing a woman to confirm ovulation retrospectively from a sustained thermal shift.Advanced protocols add urinary hormonal monitoring as a cross-check.This depth of observation allows a woman and her clinician to see, in real time, how her cycle progresses through its preovulatory, ovulatory, and postovulatory phases. A chart can show whether ovulation is occurring and how her luteal phase, bleeding pattern, and symptom profile are changing from cycle to cycle. That granularity is what separates a FABM chart from a basic period-tracking app, which mostly log only start and end dates of menstrual bleeding.Where Does This Fit Into Everyday Practice? For ob/gyns, charting offers a lifelong diagnostic roadmap for menstrual disorders, subfertility, and perimenopause, and allow investigations to be timed to a patient's biological reality rather than an arbitrary "day 21." It can be vital for identifying ovulatory dysfunction and anovulatory cycles, tracking responses to ovulation induction, and differentiating perimenopausal instability from pathology. Beyond diagnosis, it allows for assessing the impact of interventions aimed at restoring the menstrual cycle. For patients who are high-risk or ineligible for hormonal and barrier methods, FABM offers evidence-based efficacy if applied correctly, using protocols adapted for postpartum and breastfeeding when appropriate.Beyond gynecology, it can sharpen how clinicians assess and follow up patients across conditions and serves as an additional signal for management‑induced adverse effects on the cycle. In endocrinology, chronic disease care, and general practice, charting flags underlying pathology, from thyroid dysfunction to metabolic diseases, long before it becomes a crisis. Many neuropsychiatric and rheumatologic conditions show predictable worsening in specific cycle phases. This means that charting can facilitate earlier diagnosis and tailoring treatment plans to cyclical flares. The data also allows athletes to tailor training intensity to their hormonal fluctuations, optimizing performance while protecting long-term health.Far from being a niche interest, biomarker-based charting is the foundational infrastructure for personalized medicine. It moves us away from "one-size-fits-all" protocols toward a model where management is customized to a patient's unique hormonal pacing.Why Clinicians Aren't Using It, and What They Can Do The American College of Obstetricians and Gynecologists has repeatedly called the menstrual cycle a vital sign since 2006. However, physicians' knowledge and attitudes toward FABMs remains limited, even among US healthcare providers, despite FABM certification bodies being well-established. It continues to be a global and regional blind spot in medical education. Barriers other than medical training include short consultations and time constraints. In MENA, this blind spot is deepened by a lack of FABM educators and culturally competent educational resources, besides a cultural belief that often minimizes the menstrual cycle to the conception function only. Even so, almost every woman I taught FABM charting to felt empowered by owning a personal health tool that provides her with useful clues to her health journey and clinical encounters, after years of viewing their cycles as a biological black box. Bridging this diagnostic blind spot can begin with a fundamental shift in the exam room: treating the cycle as a fifth vital sign. Integrate cycle phase-linked history-taking to your routine reviews. If a patient is already tracking, invite her to share those charts; this transforms her data into shared clinical information. Finally, counsel patients about biomarker-based tools that are medically validated, invest in your own evidence-based literacy, and share it forward with colleagues. The current lag in MENA clinical practice is not due to a lack of evidence, but a clinical application gap that keeps these structured protocols out of our training and everyday practice. By reclaiming the cycle as a vital sign monitored as routinely as blood pressure, we can advance our management of women's health across multiple aspects. FABMs offer a practical way to turn something our patients are able to learn and track into a clinical tool we know how to use. Raghda Rashad, MBBS, MSc, is an Egyptian physician and the founder of Nawara Health, a health tech startup advancing women's health literacy across the MENA region. She holds a bachelor of medicine and surgery from Ain Shams University, Cairo, Egypt, and a master's degree in Global Health Sciences from the University of Oxford, United Kingdom. With more than a decade of experience in maternal and public health, she is currently based between Egypt and Saudi Arabia. Her work focuses on the intersection of public health and entrepreneurship, translating medical knowledge into scalable, patient-centered digital solutions.